ID: ALA5272184

Max Phase: Preclinical

Molecular Formula: C10H8ClN3O2S

Molecular Weight: 269.71

Representations

Canonical SMILES:  O=C(O)CSc1nnc(-c2ccc(Cl)cc2)[nH]1

Standard InChI:  InChI=1S/C10H8ClN3O2S/c11-7-3-1-6(2-4-7)9-12-10(14-13-9)17-5-8(15)16/h1-4H,5H2,(H,15,16)(H,12,13,14)

Standard InChI Key:  CNJTUQCKXPMLJE-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 269.71

Molecular Weight (Monoisotopic): 269.0026

AlogP: 2.30

#Rotatable Bonds: 4

Polar Surface Area: 78.87

Molecular Species: ACID

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.61

CX Basic pKa: 1.67

CX LogP: 2.00

CX LogD: -1.38

Aromatic Rings: 2

Heavy Atoms: 17

QED Weighted: 0.83

Np Likeness Score: -1.72

References

1. Aggarwal R, Sumran G..  (2020)  An insight on medicinal attributes of 1,2,4-triazoles.,  205  [PMID:32771798] [10.1016/j.ejmech.2020.112652]

Source

Source(1):

• Scientific Literature